Investigation Overview
An investigation on behalf of current investors in MELA Sciences, Inc. (NASDAQ:MELA) over possible breaches of fiduciary duties by certain officers and directors of MELA Sciences in connection with the recent FDA news relating MELAs skin cancer diagnosis product MelaFind was announced. On Nov. 16 2010 MELA Sciences, Inc. (NASDAQ: MELA) announced that the U.S. Food and Drug Administra...
You must register (for free) or login to view the entire investigation.